Skip to content

Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment

Early Detection of Cardiac Impairments Following Cardiotoxic Anti-cancer Treatment During Childhood and Adolescence - A Feasibility Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05261256
Enrollment
40
Registered
2022-03-02
Start date
2022-02-01
Completion date
2026-06-30
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Pediatric Cancer

Keywords

Childhood cancer, Cardiac impairments, Late effects, Early detection, Prevention, Stress echocardiography

Brief summary

This study aims at investigating the feasibility of recruitment and application of a method regarding early detection of subclinical changes in cardiac health after completion of acute cancer treatment during childhood and adolescence.

Detailed description

Cardiovascular late effects following treatment for pediatric cancer are problematic. Early detection of subclinical changes is hardly possible using conventional diagnostic methods, but seems to be feasible during physical strain (exercise stress echocardiography). This feasibility study examines as main objective the recruitment strategy and investigation method in 10-25-year olds in the first and fifth year after the end of acute anti-cancer therapy (n=40 participants with a history of childhood cancer and n=40 control subjects). The heart function is examined by means of exercise stress echocardiography and spiroergometry in comparison with healthy age- and gender-matched control subjects. Secondary aims are the evaluation of aditional echocardiography markers and levels of physical activity.

Interventions

Study participants perform an exercise stress echocardiography on a semi-supine bicycle ergometer using using a continuous incremental bicycle protocol with a work rate increment every 3 minutes according to gender and weight.

Sponsors

Technical University of Munich
Lead SponsorOTHER
Ludwig-Maximilians - University of Munich
CollaboratorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

for all participants: * Aged between 10 and 25 years * Body height of ≥1,40m (required for performing the examination on the semi supine bicycle ergometer) * Signed informed assent (minor participant) and consent (legal guardian and full-aged participant) Additional inclusion criteria for participants following cancer treatment: * Completion of acute cancer treatment with anthracyclines and/or chest radiation * End of treatment 12 months and five years ago (± three months) * Medical approval for study participation Additional inclusion criteria for healthy control subjects: \- Appropriate as matched pair with respect to age and gender

Exclusion criteria

* Known cardiovascular diseases (incoherent with cardiotoxic treatment) * Inability to follow study instructions (e.g., mental retardation, language) * Acute orthopedic injury (e.g., bone fracture) or orthopedic impairments that preclude examination on a bicycle ergometer (e.g., instable prosthetic device) All participants receive a basic physical and cardiological examination at rest as part of the study protocol to ensure capability before performing the exercise stress echocardiography.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility Criteria 1 - Recruitment RateThroughout study completion, an average of 2 yearsThe number of children, adolescents and young adults with a history of pediatric cancer who agree to participate compared to the total number approached for this study.
Feasibility Criteria 2 - AcceptanceThroughout study completion, an average of 2 yearsNumber of finished and discontinued exercise stress echocardiographies.
Feasibility Criteria 3 - Data QualityThroughout study completion, an average of 2 yearsNumber of evaluable examination data.
Feasibility Criteria 4 - PracticabilityThroughout study completion, an average of 2 yearsDifference between scheduled and required time frame for the single examination.
Feasibility Criteria 5 - Participants' FeedbackThroughout study completion, an average of 2 yearsFeedback questionnaire with multiple choice options and free text answers.

Secondary

MeasureTime frameDescription
Reference Values of Healthy PeersThroughout study completion, an average of 2 yearsAssessment of reference values from age- and gender-matched healthy peers (matched pairs).
Analysis of Echocardiography Marker 1During the procedureDeformation Parameters in % (global longitudinal strain and circumferencial strain)
Analysis of Echocardiography Marker 2During the procedureEjection Fraction (EF) in %
Analysis of Echocardiography Marker 3During the procedureM-Mode Parameter
Analysis of Echocardiography Marker 4During the procedureTricuspid Annular Plane Systolic Excursion (TAPSE) in millimeter
Analysis of Echocardiography Marker 5During the procedureLeft ventricle end diastolic volume (LVEDV) in ml/m²
Cardiorespiratory FitnessDuring the procedureSubmaximal oxygen uptake VO2peak (ml/kg/min)
Physical Activity Level post-therapyDuring the procedureFor participants with a history of pediatric cancer: Physical activity questionnaire ActiOn post-therapy for the assessment of the amount of moderate-to-vigorous physical activity.
Physical Activity Level in Healthy Control SubjectsDuring the procedureFor healthy control subjects: Physical activity questionnaire from the KiGGS study (German Health Interview and Examination Survey for Children and Adolescents).

Countries

Germany

Contacts

STUDY_CHAIRRenate Oberhoffer-Fritz, Prof. Dr. med.

Institute of Preventive Pediatrics, Department of Sport and Health Sciences, TUM

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026